Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | ANPEP | P15144 | 1/20 | 0.48 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 6/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.41 |
| ▸ | S1PR4 | O95977 | 5/20 | 0.41 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.41 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.41 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.41 |
| ▸ | ADH1B | P00325 | 1/20 | 0.39 |
| ▸ | ADH1C | P00326 | 1/20 | 0.39 |
| ▸ | ADH1A | P07327 | 1/20 | 0.39 |
| ▸ | ADH4 | P08319 | 1/20 | 0.39 |
| ▸ | ADH7 | P40394 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10398805 | 0.98 | ALDH1A1 (0.52) | TSHRALDH1A1ANPEPERAP2EPHX1 | |
| SCHEMBL8686086 | 0.98 | ALDH1A1 (0.52) | TSHRALDH1A1ANPEPERAP2EPHX1 | |
| SCHEMBL8685807 | 0.98 | ALDH1A1 (0.52) | TSHRALDH1A1ANPEPERAP2EPHX1 | |
| SCHEMBL4286294 | 0.98 | ALDH1A1 (0.52) | TSHRALDH1A1ANPEPERAP2EPHX1 | |
| Water SCHEMBL6655498 | 0.98 | TSHR (0.52) | TSHRALDH1A1ANPEPERAP2EPHX1 | |
| SCHEMBL8109480 | 0.98 | ALDH1A1 (0.52) | TSHRALDH1A1ANPEPERAP2EPHX1 | |
| SCHEMBL4141309 | 0.98 | ALDH1A1 (0.52) | TSHRALDH1A1ANPEPERAP2EPHX1 | |
| SCHEMBL8685954 | 0.98 | ALDH1A1 (0.52) | TSHRALDH1A1ANPEPERAP2EPHX1 | |
| SCHEMBL21541577 | 0.98 | ALDH1A1 (0.52) | TSHRALDH1A1ANPEPERAP2EPHX1 | |
| SCHEMBL9949418 | 0.98 | ALDH1A1 (0.52) | TSHRALDH1A1ANPEPERAP2EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150367277-A1 | Alkanolamine-Based Carbon Dioxide Absorbent Containing Polyalkylene Glycol Monomethyl Ether, and Carbon Dioxide Absorption Method and Separation Method Using Same | UNIVERSITY-INDUSTRY COOPERATION FOUNDATION OF KYUNG HEE UNIVERSITY (KR) | 2015-12-24 | — | — | US | claimed |
| US-20040116709-A1 | Process for producing optically active n-aryl-1-amino-2-propanol derivatives | KANEKA CORPORATION (JP) | 2004-06-17 | — | — | US | claimed |
| EP-1367053-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE N-ARYL-1-AMINO-2-PROPANOL DERIVATIVES | KANEKA CORPORATION (JP) | 2003-12-03 | — | — | EP | claimed |
| EP-0606590-A1 | Pharmaceutical or cosmetic composition containing N-acylalcanolamines and N-acylphospho- or lysophospholipids | RHONE-POULENC RORER GMBH (DE) | 1994-07-20 | — | — | EP | claimed |
| EP-3367997-B1 | NOVEL OCCLUSIVE FORMULATIONS | KLINGE CO CHEM PHARM FAB (DE) | 2023-12-13 | — | — | EP | disclosed |
| CN-113616540-B | Novel occlusive formulations | 株式会社LG生活健康 | 2023-11-03 | — | — | CN | disclosed |
| US-11357712-B2 | Method of use and compositions | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2022-06-14 | — | — | US | disclosed |
| US-11337900-B2 | Method of use and compositions | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2022-05-24 | — | — | US | disclosed |
| US-11324686-B2 | Occlusive formulations | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2022-05-10 | — | — | US | disclosed |
| US-11253441-B2 | Occlusive compositions | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2022-02-22 | — | — | US | disclosed |
| CN-108472228-B | Novel methods of use and compositions | 株式会社LG生活健康 | 2021-12-07 | — | — | CN | disclosed |
| CN-113616540-A | Novel occlusive formulations | 株式会社LG生活健康 | 2021-11-09 | — | — | CN | disclosed |
| WO-2002070482-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE N-ARYL-1-AMINO-2-PROPANOL DERIVATIVES | KANEKA CORPORATION (JP) | 2002-09-12 | — | — | WO | disclosed |
| EP-1148051-A2 | 1,3-dialkyl-2-imidazolidinones and a manufacturing process therefor | Mitsui Chemicals, Inc. (JP) | 2001-10-24 | — | — | EP | disclosed |
| EP-1148052-A2 | 1,3-dialkyl-2-imidazolidinones and a manufacturing process therefor | Mitsui Chemicals, Inc. (JP) | 2001-10-24 | — | — | EP | disclosed |
| CN-1256268-A | 1,3-dialkyl-2-imidazolinones and its prepn. | MITSUI CHEMICALS INC (JP) | 2000-06-14 | — | — | CN | disclosed |
| EP-0992497-A1 | 1,3-Dialkyl-2-imidazolidinones and a manufacturing process therefor | Mitsui Chemicals, Inc. (JP) | 2000-04-12 | — | — | EP | disclosed |
| EP-0882056-A2 | PREPARATION OF SURFACE-ACTIVE COMPOUNDS BASED ON LACTOSE | COÖPERATIEVE WEIPRODUKTENFABRIEK "BORCULO" W.A. (NL) | 1998-12-09 | — | — | EP | disclosed |
| WO-1997030063-A2 | PREPARATION OF SURFACE-ACTIVE COMPOUNDS BASED ON LACTOSE | COÖPERATIEVE WEIPRODUKTENFABRIEK 'BORCULO' W.A. (NL) | 1997-08-21 | — | — | WO | disclosed |
| WO-1996028458-A1 | SURFACTANT COMPOSITIONS WITH ANTI-MICROBIAL EFFECT | CASTROL LIMITED (GB) | 1996-09-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11357712-B2 | Method of use and compositions | CUTA, MGLL, PLIN5 | TSHR 4579/4885ALDH1A1 2216/4885ANPEP 3469/4885 |
| US-11337900-B2 | Method of use and compositions | CUTA, MGLL, PLIN5 | TSHR 4648/4885ALDH1A1 2078/4885ANPEP 3384/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.